Motus GI Holdings, Inc. (MOTS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 29, 2025, 3:00 PM EST
Motus GI Holdings Revenue
Motus GI Holdings had revenue of $64.00K in the quarter ending March 31, 2024, with 14.29% growth. This brings the company's revenue in the last twelve months to $327.00K, down -47.93% year-over-year. In the year 2023, Motus GI Holdings had annual revenue of $319.00K, down -46.11%.
Revenue (ttm)
327.00K
Revenue Growth
-47.93%
P/S Ratio
0.00
Revenue / Employee
21.80K
Employees
15
Market Cap
719.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 319.00K | -273.00K | -46.11% |
Dec 31, 2022 | 592.00K | 201.00K | 51.41% |
Dec 31, 2021 | 391.00K | 293.00K | 298.98% |
Dec 31, 2020 | 98.00K | -9.00K | -8.41% |
Dec 31, 2019 | 107.00K | 71.00K | 197.22% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
BioStem Technologies | 210.49M |
Motus GI Holdings News
- 9 months ago - Introducing Motus Protect: Unique Risk Management Solutions for Companies Dependent on Employee-Owned Vehicles - Business Wire
- 11 months ago - Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer - Business Wire
- 1 year ago - Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds - GlobeNewsWire
- 1 year ago - Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract - GlobeNewsWire
- 1 year ago - Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders - GlobeNewsWire
- 1 year ago - Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation - GlobeNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January - Corcept Therapeutics (NASDAQ:CORT), Kintara Therapeutics (NASDAQ:KTRA) - Benzinga